Mori S - Search Results

1

Use of Upadacitinib to Treat a Severe Flare-Up of Rheumatoid Arthritis During Anti-PD-1 Immune Checkpoint Inhibitor Therapy for Stage IV Squamous Cell Carcinoma of the Lung.

Mori S, Nakamura K, Shimamura M, Ohe K. Mori S, et al. J Clin Med. 2024 Oct 20;13(20):6257. doi: 10.3390/jcm13206257. J Clin Med. 2024. PMID: 39458207 Free PMC article.

2

Incidence of and predictive factors for lung cancer in patients with rheumatoid arthritis: A retrospective long-term follow-up study.

Mori S, Hasegawa M, Sakai F, Nakashima K, Nakamura K. Mori S, et al. Mod Rheumatol. 2024 Sep 3:roae084. doi: 10.1093/mr/roae084. Online ahead of print. Mod Rheumatol. 2024. PMID: 39223693

3

Mortality in rheumatoid arthritis patients with pulmonary nontuberculous mycobacterial disease: A retrospective cohort study.

Mori S, Koga Y, Nakamura K, Hirooka S, Matsuoka T, Uramoto H, Sakamoto O, Ueki Y. Mori S, et al. PLoS One. 2020 Dec 2;15(12):e0243110. doi: 10.1371/journal.pone.0243110. eCollection 2020. PLoS One. 2020. PMID: 33264361 Free PMC article.

4

Outcomes and risk factors for mortality in Pneumocystis pneumonia patients with rheumatoid arthritis: A multicentre retrospective cohort study.

Mori S, Ueki Y, Miyamura T, Ishii K, Hidaka T, Yoshitama T, Nakamura K, Suenaga Y. Mori S, et al. Mod Rheumatol. 2023 Jul 4;33(4):723-731. doi: 10.1093/mr/roac088. Mod Rheumatol. 2023. PMID: 35920411

5

Impact of combined pulmonary fibrosis and emphysema on lung cancer risk and mortality in rheumatoid arthritis: A multicenter retrospective cohort study.

Mori S, Ueki Y, Hasegawa M, Nakamura K, Nakashima K, Hidaka T, Ishii K, Kobayashi H, Miyamura T. Mori S, et al. PLoS One. 2024 Feb 27;19(2):e0298573. doi: 10.1371/journal.pone.0298573. eCollection 2024. PLoS One. 2024. PMID: 38412181 Free PMC article.

6

Organizing Pneumonia in Rheumatoid Arthritis Patients: A Case-Based Review.

Mori S, Koga Y, Sugimoto M. Mori S, et al. Clin Med Insights Circ Respir Pulm Med. 2015 Oct 27;9(Suppl 1):69-80. doi: 10.4137/CCRPM.S23327. eCollection 2015. Clin Med Insights Circ Respir Pulm Med. 2015. PMID: 26543387 Free PMC article. Review.

7

Different risk factors between interstitial lung disease and airway disease in rheumatoid arthritis.

Mori S, Koga Y, Sugimoto M. Mori S, et al. Respir Med. 2012 Nov;106(11):1591-9. doi: 10.1016/j.rmed.2012.07.006. Epub 2012 Aug 3. Respir Med. 2012. PMID: 22867979 Free article.

8

Pneumocystis jirovecii Pneumonia in Rheumatoid Arthritis Patients: Risks and Prophylaxis Recommendations.

Mori S, Sugimoto M. Mori S, et al. Clin Med Insights Circ Respir Pulm Med. 2015 Sep 6;9(Suppl 1):29-40. doi: 10.4137/CCRPM.S23286. eCollection 2015. Clin Med Insights Circ Respir Pulm Med. 2015. PMID: 26396551 Free PMC article. Review.

9

Management of Rheumatoid Arthritis Patients with Interstitial Lung Disease: Safety of Biological Antirheumatic Drugs and Assessment of Pulmonary Fibrosis.

Mori S. Mori S. Clin Med Insights Circ Respir Pulm Med. 2015 Sep 8;9(Suppl 1):41-9. doi: 10.4137/CCRPM.S23288. eCollection 2015. Clin Med Insights Circ Respir Pulm Med. 2015. PMID: 26401101 Free PMC article. Review.

10

Risk of venous thromboembolism associated with Janus kinase inhibitors for rheumatoid arthritis: case presentation and literature review.

Mori S, Ogata F, Tsunoda R. Mori S, et al. Clin Rheumatol. 2021 Nov;40(11):4457-4471. doi: 10.1007/s10067-021-05911-4. Epub 2021 Sep 23. Clin Rheumatol. 2021. PMID: 34554329 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,357 results

Search Page

Filters